Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

Procter & Gamble Health Ltd - 500126 - Board Meeting Outcome for Unaudited Financial Results For The Quarter Ended September 30, 2021

 We are pleased to inform you that at the meeting of the Board of Directors of the Company held today, the Unaudited Financial Results for the quarter ended September 30, 2021 were approved. We are enclosing herewith the following: a. Unaudited Financial Results for the quarter ended September 30, 2021; b. Press Release; and c. Limited Review Report in respect of the Unaudited Financial Results for the quarter ended September 30, 2021 furnished by Statutory Auditors of the Company Kindly take the same on record and oblige.
09-11-2021

Explained | Pfizer v/s Merck: New anti COVID pill and its comparison

 While Merck was the first to roll out its anti-COVID therapy, called molnupiravir, Pfizer has announced promising results of its own pill, called Paxlovid.
08-11-2021

New COVID-19 pill cut hospital, death risk by 90%, says Pfizer

 Currently all COVID-19 treatments used in the U.S. require an IV or injection. Competitor Merck's COVID-19 pill is already under review at the Food and Drug Administration after showing strong initial results, and on Thursday the United Kingdom became the first country to OK it.
05-11-2021

Merck gets UK nod, world's first Covid pill ready to be out soon

 US advisors to meet this month to vote on authorisation
05-11-2021

Gates Foundation to spend $120 million on access for Covid-19 pill

 The Bill and Melinda Gates Foundation says it will spend $120 million to boost access to generic versions of drugmaker Merck's antiviral Covid-19 pill for lower income countries
20-10-2021
Bigul

Procter & Gamble Health Ltd - 500126 - Shareholding for the Period Ended September 30, 2021

 Procter & Gamble Health Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2021. For more details, kindly Click here
19-10-2021
Bigul

Procter & Gamble Health Ltd - 500126 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 With reference to above captioned subject, on the basis of confirmation received from our Registrar and Transfer Agent, Kfin Technologies Private Limited, we confirm that the details of securities dematerialised during the quarter ended 30.09.2021 as required under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, have been furnished to the stock exchanges where the shares of the Company are listed within the prescribed time period. We enclose herewith the copy of letter received from Kfin Technologies Private Limited confirming the above.
19-10-2021

WHO-led programme aims to buy antiviral COVID-19 pills for $10

 Merck Co's experimental pill molnupiravir is likely to be one of the drugs, and other drugs to treat mild patients are being developed.
19-10-2021
Bigul

Procter & Gamble Health Ltd - 500126 - Reg. 34 (1) Annual Report

 We refer to our letter dated September 18, 2021, intimating the date of 54th Annual General Meeting. In this respect, please find enclosed Annual Report for the Financial Year ended June 30, 2021 and Notice calling the 54th Annual General Meeting of the Company. Kindly take the same on record and oblige.
18-10-2021
Bigul

Procter & Gamble Health Ltd - 500126 - Annual Report For The Financial Year Ended June 30, 2021 And Notice Calling The 54Th Annual General Meeting Of The Company

 We refer to our letter dated September 18, 2021, intimating the date of 54th Annual General Meeting. In this respect, please find enclosed Annual Report for the Financial Year ended June 30, 2021 and Notice calling the 54th Annual General Meeting of the Company. Kindly take the same on record and oblige.
18-10-2021
Next Page
Close

Let's Open Free Demat Account